GlassScriptPhysician profile
Misha D Miller
NPI 1194802371
$4,892.97
in general payments reported to CMS, 2019-2025
19 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,700 · 2022: $151 · 2023: $588 · 2024: $861 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,041.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,822.44 | 2020-2025 | |
| Abbvie INC. | $535.26 | 2022-2025 | |
| Genzyme Corporation | $223.43 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $205.09 | 2023-2025 | Levulan Kerastick, Ilumya, Blu-U |
| Lilly USA, LLC | $190.02 | 2023-2024 | Olumiant, Taltz |
| Regeneron Healthcare Solutions, INC. | $184.42 | 2023-2025 | Dupixent, Libtayo |
| Amgen INC. | $134.46 | 2023-2024 | Otezla |
| Incyte Corporation | $119.68 | 2022-2025 | Opzelura |
| Ucb, INC. | $86.10 | 2024-2025 | Bimzelx |
| Strata Skin Sciences, INC. | $77.34 | 2022 | |
| Janssen Biotech, INC. | $62.15 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Dermavant Sciences, INC. | $61.49 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $47.36 | 2024-2025 | |
| Galderma Laboratories, L.P. | $33.91 | 2023-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.01 | 2024 | Spevigo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $27.93 | 2024 | Acthar |
| Leo Pharma INC. | $19.93 | 2024 | Adbry |
| Springworks Therapeutics, INC. | $18.25 | 2025 | Gomekli |
| Helsinn Therapeutics (U.S.), INC. | $14.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misha Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.